Netrin G1 Promotes Pancreatic Tumorigenesis through Cancer-Associated Fibroblast-Driven Nutritional Support and Immunosuppression.


Journal

Cancer discovery
ISSN: 2159-8290
Titre abrégé: Cancer Discov
Pays: United States
ID NLM: 101561693

Informations de publication

Date de publication:
02 2021
Historique:
received: 01 06 2020
revised: 08 09 2020
accepted: 22 10 2020
pubmed: 1 11 2020
medline: 15 1 2022
entrez: 31 10 2020
Statut: ppublish

Résumé

Pancreatic ductal adenocarcinoma (PDAC) has a poor 5-year survival rate and lacks effective therapeutics. Therefore, it is of paramount importance to identify new targets. Using multiplex data from patient tissue, three-dimensional coculturing

Identifiants

pubmed: 33127842
pii: 2159-8290.CD-20-0775
doi: 10.1158/2159-8290.CD-20-0775
pmc: PMC7858242
mid: NIHMS1642553
doi:

Substances chimiques

Netrins 0
netrin-G1 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

446-479

Subventions

Organisme : NCI NIH HHS
ID : K99 CA234221
Pays : United States
Organisme : NCI NIH HHS
ID : R21 CA231252
Pays : United States
Organisme : NCI NIH HHS
ID : R03 CA212949
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA168653
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA188430
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA113451
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA014051
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA232256
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM116911
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA194263
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA006927
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009035
Pays : United States
Organisme : Worldwide Cancer Research
ID : 20-0081
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : F32 CA213810
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA201276
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA242379
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

©2020 American Association for Cancer Research.

Références

Mol Cancer. 2013 Dec 20;12(1):168
pubmed: 24354864
Mol Cancer. 2018 Feb 19;17(1):62
pubmed: 29458370
J Mass Spectrom. 1996 Mar;31(3):255-62
pubmed: 8799277
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Pharmacol Ther. 2018 Sep;189:31-44
pubmed: 29660367
Mol Med Rep. 2018 Nov;18(5):4716-4724
pubmed: 30221744
Sci Rep. 2016 Nov 28;6:37594
pubmed: 27892481
Mol Cell. 2014 Jul 17;55(2):253-63
pubmed: 24882210
Science. 2001 Nov 23;294(5547):1708-12
pubmed: 11721053
Elife. 2017 Jan 31;6:
pubmed: 28139197
Cancer Cell. 2014 Jun 16;25(6):719-34
pubmed: 24856586
Oncotarget. 2017 May 25;8(34):56968-56979
pubmed: 28915646
Int Rev Neurobiol. 2007;82:57-71
pubmed: 17678955
Nat Commun. 2017 Jul 03;8:15965
pubmed: 28671190
Gastroenterology. 2013 Nov;145(5):1121-32
pubmed: 23891972
Nature. 2016 Aug 25;536(7617):479-83
pubmed: 27509858
Front Neuroendocrinol. 2012 Jan;33(1):116-25
pubmed: 22214786
Front Immunol. 2017 Apr 03;8:367
pubmed: 28421073
Cancer Res. 2015 Mar 1;75(5):813-23
pubmed: 25732845
J Immunol. 2008 Sep 15;181(6):3784-92
pubmed: 18768831
Acta Neurobiol Exp (Wars). 2007;67(3):207-18
pubmed: 17957901
J Hematol Oncol. 2017 Mar 28;10(1):76
pubmed: 28351381
Science. 2009 Jun 12;324(5933):1457-61
pubmed: 19460966
Int J Mol Sci. 2017 Mar 02;18(3):
pubmed: 28257124
Neuropsychopharmacology. 2017 Jan;42(1):193-215
pubmed: 27629368
Proc Natl Acad Sci U S A. 2018 Feb 06;115(6):E1147-E1156
pubmed: 29351990
Surgery. 2011 Feb;149(2):200-8
pubmed: 20542529
Cancer Cell. 2014 Jun 16;25(6):735-47
pubmed: 24856585
Nat Commun. 2017 Jan 10;8:13989
pubmed: 28071763
Cancer Res. 2008 Feb 1;68(3):918-26
pubmed: 18245495
Neurochem Res. 2019 Apr;44(4):994-1004
pubmed: 30805800
Oncogene. 2016 Jul 14;35(28):3619-25
pubmed: 26592449
Cell Cycle. 2016;15(6):781-6
pubmed: 26901143
Genome Biol. 2014;15(12):550
pubmed: 25516281
Pediatr Neurol. 2007 Oct;37(4):270-4
pubmed: 17903671
Cancer Cell. 2005 May;7(5):469-83
pubmed: 15894267
Gastroenterology. 2018 Dec;155(6):1999-2013.e3
pubmed: 30165049
Clin Cancer Res. 2014 Dec 1;20(23):5937-5945
pubmed: 25278454
J Cell Sci. 2013 Nov 1;126(Pt 21):4926-38
pubmed: 23986473
Nat Commun. 2019 Jan 2;10(1):6
pubmed: 30602778
Exp Cell Res. 2009 Jun 10;315(10):1633-8
pubmed: 19298811
JCI Insight. 2016 Sep 8;1(14):
pubmed: 27642636
Clin Cancer Res. 2016 Dec 15;22(24):6153-6163
pubmed: 27384421
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Biomech Model Mechanobiol. 2012 Mar;11(3-4):461-73
pubmed: 21744269
Front Endocrinol (Lausanne). 2017 Sep 29;8:261
pubmed: 29085336
PLoS One. 2010 Nov 15;5(11):e13984
pubmed: 21085593
Cancer Cell. 2012 Jun 12;21(6):822-35
pubmed: 22698406
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Cancer Discov. 2020 Jul;10(7):1018-1037
pubmed: 32341021
Elife. 2019 Apr 16;8:
pubmed: 30990168
Genome Med. 2017 Apr 19;9(1):34
pubmed: 28420421
J Neurosci. 2000 Sep 1;20(17):6540-50
pubmed: 10964959
Br J Pharmacol. 2016 Dec;173(23):3292-3306
pubmed: 27747870
Cell Rep. 2020 Apr 28;31(4):107580
pubmed: 32348754
Nat Methods. 2015 Dec;12(12):1143-9
pubmed: 26501517
Front Physiol. 2014 Apr 09;5:141
pubmed: 24782785
Sci Rep. 2018 Jun 15;8(1):9227
pubmed: 29907753
Sci Rep. 2020 Mar 23;10(1):5224
pubmed: 32251318
Biotechnol Bioeng. 2008 Feb 15;99(3):686-99
pubmed: 17787013
Nat Protoc. 2014 Jan;9(1):182-92
pubmed: 24385148
Cancer Discov. 2016 Aug;6(8):886-99
pubmed: 27184426
Nucleic Acids Res. 2012 Jan;40(Database issue):D1144-9
pubmed: 22086960
Cancer Res. 2014 Jun 1;74(11):2913-21
pubmed: 24840647
Nat Genet. 2015 Oct;47(10):1168-78
pubmed: 26343385
Genes Dev. 2016 Dec 1;30(23):2623-2636
pubmed: 28007785
Cancer Discov. 2014 Jun;4(6):716-29
pubmed: 24670723
Front Immunol. 2017 Mar 08;8:248
pubmed: 28337200
Clin Gastroenterol Hepatol. 2008 Oct;6(10):1155-61
pubmed: 18639493
Cancer Cell. 2012 Mar 20;21(3):418-29
pubmed: 22439937
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Elife. 2017 Aug 15;6:
pubmed: 28826492
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Expert Rev Gastroenterol Hepatol. 2016;10(3):301-16
pubmed: 26560854
Front Immunol. 2018 Feb 23;9:353
pubmed: 29527212
Sci Rep. 2016 Jun 27;6:28750
pubmed: 27345935
Cell. 2017 May 4;169(4):570-586
pubmed: 28475890
Crit Rev Oncol Hematol. 2016 Jan;97:303-11
pubmed: 26467073
Nat Rev Cancer. 2020 Mar;20(3):174-186
pubmed: 31980749
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Elife. 2016 Sep 23;5:
pubmed: 27661255
EMBO Mol Med. 2015 Apr 01;7(6):735-53
pubmed: 25834145
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
Am J Pathol. 2005 Aug;167(2):475-88
pubmed: 16049333
Cell. 2018 Apr 5;173(2):400-416.e11
pubmed: 29625055
Cancer Cell. 2017 Nov 13;32(5):654-668.e5
pubmed: 29136508
Curr Protoc Cell Biol. 2016 Jun 01;71:10.9.1-10.9.34
pubmed: 27245425
Nature. 2019 Apr;568(7752):410-414
pubmed: 30918400
Cancers (Basel). 2019 Jul 23;11(7):
pubmed: 31340499
BMC Genomics. 2013 Jun 07;14:381
pubmed: 23758685
N Engl J Med. 2017 Dec 21;377(25):2500-2501
pubmed: 29262275
Nat Rev Neurosci. 2011 Nov 30;13(1):22-37
pubmed: 22127301
Cancer Cell. 2012 Jun 12;21(6):836-47
pubmed: 22698407
Semin Cancer Biol. 2014 Apr;25:69-77
pubmed: 24406209
Oncotarget. 2017 Aug 24;8(56):95361-95376
pubmed: 29221133
Elife. 2019 Nov 01;8:
pubmed: 31663852
Cancer Res. 2007 Mar 1;67(5):2098-106
pubmed: 17332339
BMC Bioinformatics. 2013 Jan 16;14:7
pubmed: 23323831
Surg Today. 2018 Jan;48(1):110-118
pubmed: 28702871
Cancer Cell. 2017 Aug 14;32(2):185-203.e13
pubmed: 28810144
Cell. 2013 Mar 28;153(1):86-100
pubmed: 23540692
Nature. 2013 May 30;497(7451):633-7
pubmed: 23665962
J Exp Med. 2016 Dec 12;213(13):2967-2988
pubmed: 27881732
Mol Biol Rep. 2020 Jan;47(1):737-752
pubmed: 31612408
Nature. 2012 Nov 15;491(7424):399-405
pubmed: 23103869
Digestion. 1976;14(4):360-3
pubmed: 964475
Nature. 2013 Apr 4;496(7443):101-5
pubmed: 23535601
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
Cancer Res. 2015 Jul 1;75(13):2629-40
pubmed: 25952647
Cancer Res. 2007 Oct 1;67(19):9518-27
pubmed: 17909062
Nat Neurosci. 2003 Dec;6(12):1270-6
pubmed: 14595443
N Engl J Med. 2014 Nov 27;371(22):2140-1
pubmed: 25427123
Trends Cell Biol. 2017 Nov;27(11):863-875
pubmed: 28734735
Nat Rev Gastroenterol Hepatol. 2015 Nov;12(11):649-59
pubmed: 26460352
N Engl J Med. 2010 Apr 29;362(17):1605-17
pubmed: 20427809
Mol Cancer. 2017 Apr 3;16(1):73
pubmed: 28372546
Neuropsychopharmacology. 2008 Mar;33(4):933-45
pubmed: 17507910
Elife. 2016 Feb 27;5:e10250
pubmed: 26920219
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Cancer Cell. 2003 Dec;4(6):437-50
pubmed: 14706336
Oncotarget. 2017 Oct 19;8(60):102721-102738
pubmed: 29254283
J Clin Invest. 2015 Jun;125(6):2293-306
pubmed: 25915584
Cancer Res. 2019 Aug 1;79(15):3877-3890
pubmed: 31175120
Cell Rep. 2019 Oct 29;29(5):1287-1298.e6
pubmed: 31665640
J Surg Oncol. 2017 Dec;116(8):996-1004
pubmed: 28767131
Cancer Res. 2015 Feb 1;75(3):544-53
pubmed: 25644265
Cell Metab. 2016 Nov 8;24(5):685-700
pubmed: 27829138

Auteurs

Ralph Francescone (R)

Cancer Biology Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Débora Barbosa Vendramini-Costa (D)

Cancer Biology Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Janusz Franco-Barraza (J)

Cancer Biology Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Jessica Wagner (J)

Molecular Therapeutics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Alexander Muir (A)

Koch Institute for Integrative Cancer Research and the Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts.
Ben May Department for Cancer Research, University of Chicago, Chicago, Illinois.

Allison N Lau (AN)

Koch Institute for Integrative Cancer Research and the Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts.

Linara Gabitova (L)

Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Molecular Therapeutics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Tatiana Pazina (T)

Blood Cell and Development and Function Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Sapna Gupta (S)

Cancer Biology Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Tiffany Luong (T)

Cancer Biology Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Dustin Rollins (D)

Cancer Biology Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Ruchi Malik (R)

Cancer Biology Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Roshan J Thapa (RJ)

Blood Cell and Development and Function Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Diana Restifo (D)

Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Molecular Therapeutics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Yan Zhou (Y)

Molecular Therapeutics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Biostatistics and Bioinformatics Facility, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Kathy Q Cai (KQ)

Cancer Biology Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Histopathology Facility, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Harvey H Hensley (HH)

Molecular Therapeutics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Small Animal Imaging Facility, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Yinfei Tan (Y)

Cancer Biology Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Genomics Facility, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Warren D Kruger (WD)

Cancer Biology Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Karthik Devarajan (K)

Biostatistics and Bioinformatics Facility, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Siddharth Balachandran (S)

Blood Cell and Development and Function Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Andres J Klein-Szanto (AJ)

Cancer Biology Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Histopathology Facility, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Huamin Wang (H)

Division of Pathology/Lab Medicine, Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Wafik S El-Deiry (WS)

Molecular Therapeutics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Department of Pathology and Laboratory Medicine, Warren Alpert Medical School, Brown University, Providence, Rhode Island.

Matthew G Vander Heiden (MG)

Koch Institute for Integrative Cancer Research and the Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts.
Dana-Farber Cancer Institute, Boston, Massachusetts.

Suraj Peri (S)

Biostatistics and Bioinformatics Facility, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Kerry S Campbell (KS)

Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Blood Cell and Development and Function Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Igor Astsaturov (I)

Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Molecular Therapeutics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Edna Cukierman (E)

Cancer Biology Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania. edna.cukierman@fccc.edu.
Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH